Ceramide and DNA damage in liver fibrosis: Exploring the implications of eicosapentaenoic acid encapsulation in cellulose nanocrystals
-
Published:2025-06
Issue:
Volume:178
Page:106985
-
ISSN:1098-8823
-
Container-title:Prostaglandins & Other Lipid Mediators
-
language:en
-
Short-container-title:Prostaglandins & Other Lipid Mediators
Author:
Hussein Jihan,
El-Bana Mona A.,
Mohamed Rehab A.,
Omara Enayat,
Medhat DaliaORCID
Funder
National Research Centre
Reference43 articles.
1. Liver cirrhosis;Schuppan;Lancet (Lond., Engl. ),2008
2. Pathogenesis of liver fibrosis;Hernandez-Gea;Annu. Rev. Pathol.,2011
3. Inhibiting ceramide synthesis attenuates hepatic steatosis and fibrosis in rats with non-alcoholic fatty liver disease;Jiang;Front. Endocrinol.,2019
4. IL-6 in inflammation, immunity, and disease;Tanaka;Cold Spring Harb. Perspect. Biol.,2014
5. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism;Holland;Endocr. Rev.,2008